AU765515B2 - Endometriosis-associated gene - Google Patents

Endometriosis-associated gene Download PDF

Info

Publication number
AU765515B2
AU765515B2 AU45024/99A AU4502499A AU765515B2 AU 765515 B2 AU765515 B2 AU 765515B2 AU 45024/99 A AU45024/99 A AU 45024/99A AU 4502499 A AU4502499 A AU 4502499A AU 765515 B2 AU765515 B2 AU 765515B2
Authority
AU
Australia
Prior art keywords
thr
ser
nucleic acid
ala
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU45024/99A
Other languages
English (en)
Other versions
AU4502499A (en
Inventor
Heike Handrow-Metzmacher
Silvia Kotzian
Anna Starzinski-Powitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4502499A publication Critical patent/AU4502499A/en
Application granted granted Critical
Publication of AU765515B2 publication Critical patent/AU765515B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU45024/99A 1998-05-29 1999-05-28 Endometriosis-associated gene Ceased AU765515B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19824230A DE19824230A1 (de) 1998-05-29 1998-05-29 Neues Endometriose-assoziiertes Gen
DE19824230 1998-05-29
PCT/EP1999/003716 WO1999063079A1 (de) 1998-05-29 1999-05-28 Endometriose-assoziiertes gen

Publications (2)

Publication Number Publication Date
AU4502499A AU4502499A (en) 1999-12-20
AU765515B2 true AU765515B2 (en) 2003-09-18

Family

ID=7869409

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45024/99A Ceased AU765515B2 (en) 1998-05-29 1999-05-28 Endometriosis-associated gene

Country Status (9)

Country Link
US (1) US6586569B1 (enExample)
EP (1) EP1080195A1 (enExample)
JP (1) JP2002517193A (enExample)
CN (1) CN1307636A (enExample)
AU (1) AU765515B2 (enExample)
CA (1) CA2329527A1 (enExample)
DE (1) DE19824230A1 (enExample)
NZ (1) NZ508439A (enExample)
WO (1) WO1999063079A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1801236B1 (en) * 2000-02-25 2009-11-18 Siemens Healthcare Diagnostics Inc. Endometriosis related markers and uses thereof
DE60140580D1 (de) 2000-02-25 2009-12-31 Siemens Healthcare Diagnostics Endometriose Marker und Verwendung derselben
DE10048633A1 (de) * 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
US6780594B2 (en) 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
US9777312B2 (en) * 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
FR2855315B1 (fr) 2003-05-23 2005-08-19 Centre Nat Rech Scient Ferrofluides stables en milieu neutre et ferrofluides modifies obtenus par modification de la surface des particules de ces ferrofluides
US20080305967A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Genetic Markers Associated with Endometriosis and Use Thereof
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
CN112180099B (zh) * 2020-09-15 2022-07-29 江南大学附属医院 子宫内膜异位症血清标志物的应用
CN113512584B (zh) * 2021-06-24 2022-03-25 南京鼓楼医院 Pbk/topk在诊断和治疗薄型内膜疾病中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4846793A (en) * 1992-09-04 1994-03-29 Baylor College Of Medicine Novel triplex forming oligonucleotides and methods for their use
WO1994028021A1 (en) * 1993-05-28 1994-12-08 Medical University Of South Carolina Endometrial proteins, antigenic compositions and methods for detecting endometriosis
AU687508B2 (en) * 1993-12-17 1998-02-26 Ohio State University, The Antisense oligonucleotides to suppress eicosanoid formation
AU6029396A (en) * 1995-06-07 1996-12-30 University Of Rochester Mammalian prostaglandin h synthase-2
DE19548122A1 (de) * 1995-12-21 1997-06-26 Joern Prof Dr Bullerdiek Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben
JP2001501300A (ja) * 1996-09-06 2001-01-30 オステオメーター・ビオテク・エー／エス ヒト子宮内膜の生化学的マーカー

Also Published As

Publication number Publication date
US6586569B1 (en) 2003-07-01
US20030109018A1 (en) 2003-06-12
EP1080195A1 (de) 2001-03-07
CA2329527A1 (en) 1999-12-09
CN1307636A (zh) 2001-08-08
WO1999063079A1 (de) 1999-12-09
JP2002517193A (ja) 2002-06-18
AU4502499A (en) 1999-12-20
NZ508439A (en) 2004-02-27
DE19824230A1 (de) 1999-12-02

Similar Documents

Publication Publication Date Title
AU765515B2 (en) Endometriosis-associated gene
Ellmeier et al. Mutually exclusive expression of a helix‐loop‐helix gene and N‐myc in human neuroblastomas and in normal development.
US5985598A (en) TCL-1 gene and protein and related methods and compositions
Begley et al. Molecular characterization of NSCL, a gene encoding a helix-loop-helix protein expressed in the developing nervous system.
WO1997006256A2 (en) Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis
US20030005471A1 (en) PAR, a novel marker gene for breast and prostate cancers
HUT77578A (hu) A 10-es számú fibroblaszt növekedési faktor (FGF-10)
Coy et al. Pore membrane and/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms
WO1995018225A1 (en) Polycystic kidney disease 1 gene and uses thereof
Larsen et al. The WFDC1 gene encoding ps20 localizes to 16q24, a region of LOH in multiple cancers
AU777096B2 (en) Differentially expressed genes associated with Her-2/neu overexpression
EP0825198A1 (en) Plag gene family and tumorigenesis
Verlaet et al. Genetic imbalances in preleukemic thymuses
JP4297209B2 (ja) Ｋｉａａ０１７２遺伝子の疾病治療及び診断並びに創薬への利用
AU749907B2 (en) Process for the determination of CTp11 and for determining whether a tumor sample has metastatic potential
JP4129227B2 (ja) 神経芽細胞腫において単離された核酸
US20080187527A1 (en) Novel endometriosis-associated gene
US6686163B2 (en) Coding sequence haplotype of the human BRCA1 gene
US6770477B1 (en) Differentially expressed genes associated with HER-2/neu overexpression
US20030104418A1 (en) Diagnostic markers for breast cancer
AU784629B2 (en) Tumour suppressor factor
AU775409B2 (en) Meg-3 protein
WO1998006871A1 (en) Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma
JPH1118777A (ja) 新規スリット様ポリペプチド
EP0994946A1 (en) Coding sequence haplotypes of the human brca2 gene

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)